ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag protein engineering microbiology evolution immunology

A needle drawing up fluid from an unlabeled vial.
Cancer Vaccination as a Promising New Treatment Against Tumors
Shelby Bradford, PhD | Mar 15, 2024 | 10+ min read
Vaccination has beaten back infections for more than a century. Now, it may be the next big step in battling cancer.
Bugs as Drugs to Boost Cancer Therapy
Danielle Gerhard, PhD | Jan 18, 2024 | 7 min read
Bioengineered bacteria sneak past solid tumor defenses to guide CAR T cells’ attacks.
T regulatory cell in red sandwiching an antigen presenting cell in blue
Gut Bacteria Help T Cells Heal Muscle: Study
Natalia Mesa, PhD | Mar 14, 2023 | 4 min read
Regulatory T cells in the colon travel to muscles to promote wound healing in mice, raising questions about how antibiotics may impact injury recovery.
Researchers in George Church&rsquo;s lab modified wild type ADK proteins (left) in <em >E.coli</em>, furnishing them with an nonstandard amino acid (nsAA) meant to biocontain the resulting bacterial strain.
A Pioneer of The Multiplex Frontier
Rashmi Shivni, Drug Discovery News | May 20, 2023 | 10 min read
George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.
Mounting Threat Of Infectious Diseases Contributes To Rising Need For Immunology Research Specialists
Marcia Clemmitt | Mar 21, 1993 | 10 min read
In today's otherwise sluggish biomedical job market, career prospects for these scientists are improving in academia as well as industry Immunology research is riding the crest of a wave, with significant laboratory results proliferating, observers of the field say. "Immunology remains one area in biomedicine that has relatively good prospectives for employment, and one that is likely to continue doing somewhat better than most others," says Robert Rich, a professor of microbiology, immuno
Life Science
Simon Silver | Jan 7, 1990 | 6 min read
Department of Microbiology & Immunology University of Illinois Chicago - Through cloning and sequence analysis, researchers have identified the primary gene of the hereditary disease muscular dystrophy, thus leading to the characterizing of the primary protein product. Deletions contributing to an absence of the polypeptide dystrophin (0.002% of total muscle protein and 3,685 amino acids long) on the inner surface of the plasma membrane appear to be the primary cause for two types of muscul
monoclonal antibody antibodies sars-cov-2 covid-19 coronavirus pandemic eli lilly receptor binding domain spike protein
First Antibody Trial Launched in COVID-19 Patients
Katarina Zimmer | Jun 2, 2020 | 8 min read
In record time, scientists have gone from harvesting antibodies against SARS-CoV-2 from survivors of coronavirus infections to testing the antibodies’ safety as a drug in humans.
Articles Alert
Simon Silver | Oct 14, 1990 | 5 min read
Author: SIMON SILVER Department of Microbiology & Immunology University of Illinois Chicago The Luddites have mostly won during the 15 years of recombinant DNA research and debates. An FDA report concludes that bovine growth hormone presents no increased health risk. Yet the combination of building political bases and mounting irrational fear of genetic engineering means that we will probably continue to be protected from this unreal danger. Our students have questioning minds, so this compilat
A Movable Defense
Eugene V. Koonin and Mart Krupovic | Jan 1, 2015 | 10 min read
In the evolutionary arms race between pathogens and hosts, genetic elements known as transposons are regularly recruited as assault weapons for cellular defense.
Suited to a T
Kelly Rae Chi | May 1, 2013 | 8 min read
Sorting out T-cell functional and phenotypic heterogeneity depends on studying single cells.

Run a Search

ADVERTISEMENT